IMD-511

N/A

Report date: 2023/12/27 10:39:39

Base Information

Drug NameIMD-511
Drug Alias NameIMD511IMD-511
ClassificationBiologics
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsT cell surface glycoprotein CD3 inhibitors
TargetsReceptor protein-tyrosine kinase erbB-2T cell surface glycoprotein CD3
Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesShanghai Affinity Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Affinity Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A